Tom Wells, Life Sciences Director at 4C, is featured in Clinical Leader’s latest article, where he unpacks common pitfalls that early-stage biotech companies face once they’ve raised their Series A funding:

Tom discusses:

  • The challenges of transitioning from financing to clinical trials
  • The strategic missteps that can derail trial progress, such as trial design, regulatory hurdles, and operational execution.

Read the full article here: You Just Secured $50 Million. Now On To The Hard Part: Clinical Trials

To find out more, contact Tom Wells or our Life Sciences team to discuss how we can support your journey.